DIMO, a leading diversified conglomerate in Sri Lanka, with its recent expansion into pharmaceutical sector has now realigned all its healthcare operations under new identity of “DIMO Healthcare”.
DIMO has been at the forefront of the nation’s healthcare sector by providing state-of-the-art medical equipment in the fields of radiology, ophthalmology, neurology, cardiology, and oncology for over 7 decades. Adding more value to country’s healthcare sector, DIMO expanded into healthcare devices, consumables, contrast mediums, and most recently into pharmaceuticals.
Aligned with its strategic vision, the company recently acquired Mansel Ceylon (Private) Limited and Associated Laboratories (Private) Limited, expanding into pharmaceutical field. This recent acquisition enables DIMO Healthcare to offer over 250 pharmaceutical products that cover Pain Management, Respiratory Disorders, Gastroenterology, Liver Diseases, Antibiotics, Endocrinology, Cardiovascular Antihistamine, Vitamins & Supplements, Neurology, Dermatology, and Psychiatric treatment from renowned pharmaceutical manufacturers such as Medochemie Ltd – Cyprus, Grifols Inc – USA, Hetero Ltd – India, PT. Harsen – Indonesia, Hovid Bhd – Malaysia, Geno Pharmaceuticals Ltd – India, and Tabros Pharma (Pvt) Ltd – Pakistan just to name a few. DIMO Healthcare pharmaceutical arm also consists of an island-wide distribution network facilitating easy access for medicine.
Mr. Ranjith Pandithage, Chairman & Managing Director of DIMO, said, “Under this bold new identity DIMO Healthcare, we aim to expand the horizons of Sri Lanka’s healthcare sector with our objective of Building a Healthier Nation. Our strategic vision has given us opportunities to facilitate multiple spectrums of the healthcare sector, and we are confident that it will play a significant role in fuelling the dreams and aspirations of the communities we serve, within our efforts in building a healthier nation.”
Mr. Wijith Pushpawela, Executive Director of DIMO who is also oversees healthcare segment of the group said, “DIMO has always led the way in providing the latest internationally renowned technology to the local healthcare sector. It is after much careful consideration, that we chose consumables, devices, contrast mediums, and pharmaceutical brands, that would further enhance our reputation within the healthcare sector.”
DIMO Healthcare has been a leader in various areas of the Medical Equipment industry including radiology, ophthalmology, critical care, cardiology, oncology, urology, and neonatal care by offering products from world renowned manufacturers such as Siemens Healthineers, Carl Zeiss, Draeger and more. In terms of the Implants segment, the company provides cardiac stents, X ray accessories, mechanical heart valves, catheters, and pacemakers from internationally reputed principals such as Boston Scientific, St. Jude and more. In the Consumables & Contrast Mediums sector, the company provides medical printers, monitors, pressure indicators and accessories for neonatal care, critical care, anaesthesiology and immobilization accessories for radiation therapy and diagnostics from Sony & Codonics.
DIMO Healthcare is the largest provider of PET scanners, MRI scanners and operating microscopes in Sri Lanka covering every part of the island. The radiology equipment such as MRI, CT, and PET-CT scanners supplied by DIMO Healthcare serves 525,643 patients per annum, while the operating microscopes perform 213,000 surgeries & over 1.5mn diagnostic tests per year. The company also have supplied Sri Lanka’s First Tomotherapy unit bringing the latest technology to the country. DIMO Healthcare is equipped with unparalleled after sales service as the service aspect plays a crucial role for uninterrupted functionality of these medical equipment.
Coupled with DIMO’s focus on sustainability, innovation, management expertise, centralized logistics, and SAP, the state-of-the-art ERP, DIMO Healthcare is geared to grow exponentially within the healthcare sector.
